165 related articles for article (PubMed ID: 12944557)
1. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope.
Bodger K; Campbell F; Rhodes JM
J Clin Pathol; 2003 Sep; 56(9):703-8. PubMed ID: 12944557
[TBL] [Abstract][Full Text] [Related]
2. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus.
Torrado J; Ruiz B; Garay J; Asenjo JL; Tovar JA; Cosme A; Correa P
Am J Surg Pathol; 1997 Sep; 21(9):1023-9. PubMed ID: 9298878
[TBL] [Abstract][Full Text] [Related]
3. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
4. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
5. Can we diagnose early Barrett's oesophagus?
Tandon H; Kini U; Nirmala V
J Assoc Physicians India; 1999 Oct; 47(10):973-5. PubMed ID: 10778690
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan.
Azuma N; Endo T; Arimura Y; Motoya S; Itoh F; Hinoda Y; Irimura T; Hosokawa M; Imai K
J Gastroenterol; 2000; 35(8):583-92. PubMed ID: 10955596
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic differences between esophageal and gastric intestinal metaplasia.
Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
[TBL] [Abstract][Full Text] [Related]
8. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma.
Endo T; Tamaki K; Arimura Y; Itoh F; Hinoda Y; Hareyama M; Irimura T; Fujita M; Imai K
J Gastroenterol; 1998 Dec; 33(6):811-5. PubMed ID: 9853552
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
10. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction.
Chen YY; Wang HH; Antonioli DA; Spechler SJ; Zeroogian JM; Goyal R; Shahsafaei A; Odze RD
Hum Pathol; 1999 Dec; 30(12):1488-95. PubMed ID: 10667428
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
[TBL] [Abstract][Full Text] [Related]
12. Novel carbohydrate specificity of monoclonal antibody 91.9H prepared against human colonic sulfomucin: recognition of sulfo-Lewis(a) structure.
Tsuiji H; Hong JC; Kim YS; Ikehara Y; Narimatsu H; Irimura T
Biochem Biophys Res Commun; 1998 Dec; 253(2):374-81. PubMed ID: 9878545
[TBL] [Abstract][Full Text] [Related]
13. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
[TBL] [Abstract][Full Text] [Related]
14. Intestinal metaplasia subtyping: evaluation of Gomori's aldehyde fuchsin for routine diagnostic use.
Shah KA; Deacon AJ; Dunscombe P; Price AB
Histopathology; 1997 Sep; 31(3):277-83. PubMed ID: 9354900
[TBL] [Abstract][Full Text] [Related]
15. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas.
Matsukura N; Suzuki K; Kawachi T; Aoyagi M; Sugimura T; Kitaoka H; Numajiri H; Shirota A; Itabashi M; Hirota T
J Natl Cancer Inst; 1980 Aug; 65(2):231-40. PubMed ID: 6931245
[TBL] [Abstract][Full Text] [Related]
16. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
17. Mucins as key molecules for the classification of intestinal metaplasia of the stomach.
Silva E; Teixeira A; David L; Carneiro F; Reis CA; Sobrinho-Simões J; Serpa J; Veerman E; Bolscher J; Sobrinho-Simões M
Virchows Arch; 2002 Mar; 440(3):311-7. PubMed ID: 11889603
[TBL] [Abstract][Full Text] [Related]
18. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
19. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.
Chaves P; Cardoso P; de Almeida JC; Pereira AD; Leitao CN; Soares J
Hum Pathol; 1999 Nov; 30(11):1291-5. PubMed ID: 10571507
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical mucin expression of short-segment Barrett's esophagus.
Yamamoto S; Kijima H; Hara T; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Tokai J Exp Clin Med; 2003 Jul; 28(2):57-63. PubMed ID: 14714830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
